comparemela.com

Page 4 - Peter Braun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TargImmune Announces Another Senior Hire as Veronica Hersberger Revealed As New Chief Medical Officer

/PRNewswire/ TargImmune Therapeutics AG, a privately owned Swiss-based biotechnology company dedicated to significantly improving the survival of cancer.

Peter braunGlobal product leaderInvestigational new drug applicationClinical trial applicationAimmune therapeuticsTargimmune therapeutics ag

Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021

/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces its results for the second quarter and first half 2021. A presentation by Nordic Nanovector s.

Peter braunFrazer hall davidSolveig hellebustHilde hermansen steinegerMalene brondbergNordic nanovectorPrivate placementRepair offeringRefractory diffuse largeb cell lymphomaChief executive officerHermansen steinegerNon executive directorDavid dibleSecurities trading

Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer

Nordic Nanovector Appoints Malene Brondberg as Interim Chief Executive Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Peter braunFrazer hall davidJanh egbertsSundal collierMalene brondbergGlobal head of researchCommittee of the nordicChief executive officerChief financial officerNordic nanovectorVice president investor relationsGlobal headExecutive committeeDavid dibleAbuse regulationNorwegian securities trading

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma

/PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) announces initial promising data from the Archer-1 Phase 1b trial investigating Betalutin® (177Lu lilotomab.

Peter braunFrazer hall davidMalene brondbergNordic nanovectorDavid dibleCitigate dewe rogersonSecurities tradingபீட்டர் மூளைஃப்ரேசர் மண்டபம் டேவிட்டேவிட் டிபிலேபத்திரங்கள் வர்த்தக

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Peter braunFrazer hall davidMalene brondbergNordic nanovectorDavid dibleCitigate dewe rogersonSecurities tradingபீட்டர் மூளைஃப்ரேசர் மண்டபம் டேவிட்டேவிட் டிபிலேபத்திரங்கள் வர்த்தக

vimarsana © 2020. All Rights Reserved.